Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria

The Journal of Infectious Diseases
R DarouicheS Tsai

Abstract

To predict the efficacy of antibiotics in eliminating nasopharyngeal carriage of organisms such as Neisseria meningitidis, Haemophilus influenzae, and methicillin-resistant Staphylococcus aureus (MRSA), a novel approach for measuring drug concentrations in nasal secretions was developed. Five healthy individuals received four doses of rifampin and then, at a later date, ciprofloxacin. At 2, 5, and 8 h after the last dose, serum, saliva, and cold-stimulated nasal secretion samples were collected, and drug levels were analyzed by high-performance liquid chromatography. Nasopharyngeal levels of rifampin reached but did not substantially exceed 90% of the minimal inhibitory concentration (MIC90) for H. influenzae, exceeded the MIC90 for N. meningitidis, and were well above that for MRSA. Ciprofloxacin levels in nasal secretions far exceeded the MIC90 for meningococci and Haemophilus organisms but were below that for MRSA. These findings are consistent with the clinical studies showing that rifampin eliminates, in most instances, the nasal carriage of N. meningitidis and to a lesser extent H. influenzae. A single dose of ciprofloxacin has been shown to eradicate meningococci, yet a long course of treatment with this drug is not adeq...Continue Reading

Citations

Jun 1, 1997·International Journal of Antimicrobial Agents·F J Schmitz, M E Jones
Jul 1, 2009·The Journal of Infectious Diseases·Bruno FantinFrance Mentré
Feb 1, 1997·The Pediatric Infectious Disease Journal·G L Darmstadt
May 3, 2001·The Pediatric Infectious Disease Journal·M FernandezC J Baker
May 6, 1999·Current Opinion in Pulmonary Medicine·D A MooreJ S Friedland
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·S A Brown
Sep 30, 2010·Antimicrobial Agents and Chemotherapy·Victoire de LastoursBruno Fantin
Nov 20, 2004·Emerging Infectious Diseases·Pak-Leung HoSusan S Chiu
Jul 27, 2014·The Journal of Antimicrobial Chemotherapy·Victoire de LastoursBruno Fantin
Jun 30, 2015·Future Microbiology·Victoire de Lastours, Bruno Fantin
Jun 10, 2014·La Revue de médecine interne·V de Lastours, B Fantin
Apr 9, 2001·The Journal of Pharmacy and Pharmacology·S Jaruratanasirikul, S Sriwiriyajan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.